|
| Status |
Public on Dec 07, 2020 |
| Title |
Dynamic IFNβ signalling underlies treatment response to immune checkpoint therapy in cancer |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
35986006 |
| |
| Submission date |
Jul 07, 2020 |
| Last update date |
Sep 14, 2022 |
| Contact name |
Wee Loong Chin |
| Organization name |
National Centre For Asbestos Related Diseases
|
| Street address |
Level 5, Qq Block, Qeii Medical Centre 6 Verdun St, Nedlands
|
| City |
Perth |
| ZIP/Postal code |
6009 |
| Country |
Australia |
| |
|
| Platforms (1) |
| GPL13112 |
Illumina HiSeq 2000 (Mus musculus) |
|
| Samples (164)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE153941 |
Dynamic IFNβ signalling underlies treatment response to immune checkpoint therapy in cancer [bulk RNA-seq] |
| GSE153942 |
Dynamic IFNβ signalling underlies treatment response to immune checkpoint therapy in cancer [single-cell RNA-seq] |
| GSE213296 |
Time-course bulk RNAseq and single-cell RNAseq of murine AB1 mesothelioma and Renca renal cancer following immune checkpoint therapy |
|
| Relations |
| BioProject |
PRJNA644586 |
Less...
More...